Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer

最低点 医学 阶段(地层学) 放化疗 肿瘤科 血红蛋白 内科学 肺癌 癌症 卫星 生物 工程类 航空航天工程 古生物学
作者
Erkan Topkan,Uğur Selek,Yurday Özdemir,Berna Akkuş Yıldırım,Ozan Cem Güler,Hüseyin Mertsoylu,Stephen M. Hahn
出处
期刊:Lung Cancer [Elsevier BV]
卷期号:121: 30-36 被引量:18
标识
DOI:10.1016/j.lungcan.2018.04.016
摘要

We investigated the influence of change in hemoglobin (Hgb) levels during concurrent chemoradiotherapy (C-CRT) on outcomes of non-anemic patients with stage IIIA/B non-small cell lung cancer (NSCLC).We identified 722 patients with stage IIIA/B NSCLC without anemia at baseline [hemoglobin (Hgb) <12 g/dL for women or <13 g/dL for men], either nonsmokers or ex-smokers, who received C-CRT between 2007 and 2012. All patients had received 1-3 cycles of platinum-based doublet chemotherapy during radiotherapy to 60-66 Gy and had documented Hgb measurements before treatment and at weekly intervals for 6 weeks during the C-CRT. Potential associations were assessed between baseline, nadir, extent of change in Hgb level, and anemia and overall survival (OS), locoregional progression-free survival (LRPFS), and PFS.The median baseline Hgb level was 13.9 g/dL (range 12.0-16.8) and declined to a median 12.4 g/dL (range 7.9-16.1) during treatment. Anemia appeared in 237 patients (32.8%) and was more common among women (44.8% vs. 26.5%, P < 0.001). Neither baseline Hgb level nor change during treatment nor anemia emergence influenced any survival endpoint. Receiver operating curve analysis revealed an Hgb nadir of 11.1 g/dL to be associated with outcomes, in that a nadir Hgb <11.1 g/dL (in 156 patients) was linked with shorter median OS time (P < 0.001), LRPFS time (P < 0.001), and PFS time (P < 0.001); retained significance for all three endpoints in multivariate analyses; and was more strongly associated with OS in squamous cell carcinoma (P < 0.001) than in adenocarcinoma (P = 0.009).Nadir Hgb <11.1 g/dL levels during C-CRT were associated with significantly poorer survival times in initially non-anemic patients presenting with locally advanced NSCLC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Andyvictory完成签到,获得积分10
1秒前
啦啦完成签到,获得积分10
1秒前
炸毛小猫咪完成签到 ,获得积分20
1秒前
高挑的寒天完成签到,获得积分10
2秒前
拼搏凝冬完成签到,获得积分10
2秒前
luqong完成签到,获得积分0
2秒前
2秒前
2秒前
3秒前
Emily完成签到,获得积分10
3秒前
无极微光的应助被577呀采纳,获得20
3秒前
HALO发布了新的文献求助10
3秒前
3秒前
3秒前
LQQy27完成签到,获得积分10
3秒前
qwdqwqwqwq发布了新的文献求助10
4秒前
深情中恶完成签到 ,获得积分10
4秒前
AstrLees完成签到 ,获得积分10
4秒前
隐形曼青的应助被小北采纳,获得10
5秒前
5秒前
海伦完成签到,获得积分10
5秒前
木林森发布了新的文献求助10
5秒前
Di喵喵完成签到,获得积分10
5秒前
IFevan完成签到,获得积分10
6秒前
6秒前
哦吼完成签到,获得积分10
6秒前
赵芳完成签到,获得积分10
6秒前
阳光蚂蚁完成签到,获得积分10
6秒前
郭擎擎完成签到,获得积分10
7秒前
7秒前
7秒前
星空发布了新的文献求助10
7秒前
8秒前
Youdge发布了新的文献求助10
8秒前
wojiaojzc完成签到,获得积分10
8秒前
Boyce完成签到,获得积分10
8秒前
JinFFyy完成签到,获得积分10
8秒前
焦糖布丁完成签到,获得积分10
8秒前
建成发布了新的文献求助20
8秒前
gyusbjshaxb完成签到,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180531
求助须知:如何正确求助?哪些是违规求助? 9570507
关于积分的说明 21812974
捐赠科研通 7776619
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557539
邀请新用户注册赠送积分活动 2479185